People with selected variants of the ERAP2 and TICAM2 genes were 40% more likely to survive the Black Death, researchers discovered. However, in modern humans, those with the ERAP2 gene are more likely to suffer autoimmune disorders such as Crohn's disease.
Researchers show how inflammation in pregnant mice can trigger excessive division of neural stem cells in their offspring. This can result in an overgrowth of the brain and autism like behaviors.
People with OCD have six times higher Immuno-moodulin (Imood) expression that those without the disorder. Blocking Imood with the aid of an antibody reduced OCD-like behaviors in mouse models within a couple of days following treatment.
Researchers report microvesicle injections can restore cognition following radiation treatments without adverse side effects.
Using a highly versatile form of CRISPR gene editing, researchers successfully restored vision in mice with retinitis pigmentosa.
An enzyme that relays signals between mitochondria and the immune system is involved in cell death, a new study reports.
Using patient-derived adult stem cells, researchers found fish oil created an antidepressant response.
Until recently, the production of pluripotent “multipurpose” stem cells from skin cells was considered to be the ultimate new development....
A new study reveals, in combination to genetics and environmental factors, placenta health during fetal development may play a role in schizophrenia. Researchers report genes associated with schizophrenia may turn on in the placenta during complicated pregnancies.
A large genome-wide study of over 200,000 veterans reveals six genetic variants linked to anxiety. Some of the variants have previously been linked to risk factors for PTSD, schizophrenia, and bipolar disorder. The findings provide the first convincing molecular explanation for the link between depression and anxiety.
Researchers identify five biological indicators that have a significant impact on biological aging.
Researchers have discovered a new biomarker that can help diagnose Huntington's disease. They note the findings could result in the development of treatments to postpone neuron death in those who carry the Huntington's gene mutation, but who do not currently show symptoms of the disease.